Actualités Drug Free Solutions Inc (PK) - DSOL | Actions OTCMarkets

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Termination of Registration of a Class of Security Under Section 13 and 15(d) (15-15d)

UNITED STATES SECURITIES AND EXCHANGE...

Amended Current Report Filing (8-k/a)

UNITED STATES SECURITIES AND EXCHANGE...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Wash...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K...

Quarterly Report (10-q)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q x QUARTERLY REPORT...

Notification That Annual Report Will Be Submitted Late (nt 10-k)

UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING...

Drug Free Solution, Inc. Signs Agreement for $3,000,000 Equity Line

Drug Free Solution, Inc. Signs Agreement for $3,000,000 Equity Line Company forges ahead to assist communities and individuals caught up in this...

Crowdfund Television with Donald Baillargeon and Kevin Harrington, 6/24

Crowdfund Television with Donald Baillargeon and Kevin Harrington, 6/24 PR Newswire LOS ANGELES, June 24, 2014 LOS ANGELES, June 24, 2014...

Notification That Quarterly Report Will Be Submitted Late (nt 10-q)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM...

Current Report Filing (8-k)

UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549 FORM 8-K CURRENT REPORTPursuant to Section 13 or 15(d) of the...

Designate a New Effective Date for a Post-effective Amendment Previously Filed Pursuant to Rule 485(a) (485bxt)

As filed with the Securities and Exchange Commission on October 15, 2013 Registration Nos. 333-89822;...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Drug Free Solutions Inc (PK) (DSOL)

Outils de qualité professionnelle, pour des investisseurs individuels.

DSOL Actualités

Termination of Registration of a Class of Security Under Section 13 and 15(d) (15-15d)

Amended Current Report Filing (8-k/a)

Current Report Filing (8-k)

Current Report Filing (8-k)

Current Report Filing (8-k)

Current Report Filing (8-k)

Current Report Filing (8-k)

Quarterly Report (10-q)

Notification That Annual Report Will Be Submitted Late (nt 10-k)

Drug Free Solution, Inc. Signs Agreement for $3,000,000 Equity Line

Crowdfund Television with Donald Baillargeon and Kevin Harrington, 6/24

Notification That Quarterly Report Will Be Submitted Late (nt 10-q)

Current Report Filing (8-k)

Designate a New Effective Date for a Post-effective Amendment Previously Filed Pursuant to Rule 485(a) (485bxt)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Drug Free Solutions Inc (PK) (DSOL) Actualités

Drug Free Solutions Inc (PK) (DSOL)

Outils de qualité professionnelle, pour des investisseurs individuels.

DSOL Actualités

Termination of Registration of a Class of Security Under Section 13 and 15(d) (15-15d)

Amended Current Report Filing (8-k/a)

Current Report Filing (8-k)

Current Report Filing (8-k)

Current Report Filing (8-k)

Current Report Filing (8-k)

Current Report Filing (8-k)

Quarterly Report (10-q)

Notification That Annual Report Will Be Submitted Late (nt 10-k)

Drug Free Solution, Inc. Signs Agreement for $3,000,000 Equity Line

Crowdfund Television with Donald Baillargeon and Kevin Harrington, 6/24

Notification That Quarterly Report Will Be Submitted Late (nt 10-q)

Current Report Filing (8-k)

Designate a New Effective Date for a Post-effective Amendment Previously Filed Pursuant to Rule 485(a) (485bxt)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application